Document 8RObkVnMroo2ev9y5ejpM9Nak

FILE NAME Talc TALC DATE 1976 Mar DOC TALC152 DOCUMENT DESCRIPTION Meeting Minutes - CTFA Talc Task Force ieef aOeTheThe and CosmeticToiletry Fragrance Association ek nd is et en citite nes ow Not 1133 15th STREETSTREET N.W. WASHINGTON D.C. - 20005- 331-1770 TELEX 89-2673 Inc. James H. Merritt President Norman F. Estrin Ph Vice $ resident- Smcence MINUTES CTFA TALC TASK FORCE ea A meeting of the CTFA T^lcTask Force was held on a * th 1976 at the CTFA offices in Washington D.C. Those in attendance were a George Sandland Bristol Company Chairman ae John Clements Pfizer Inc. Ray Krammer , Whittaker Clark Daniels George Lee Johnson & Johnson Baby Products Company Monroe Messinger Chesebrough Inc. Minerals Roderick A. Mundy Sterling Drug Inc. Louis D. Murino Cyprus Industrial Minerals Company D.R Petterson Johnson & Johnson Baby Products Company Fred Roesch Whittaker Clark & DanielsProducts Robert Rolle Johnson & Johnson Baby Products Company Raby John P. Schelz Johnson & Johnson Inc. Maurice Siegel Faberge Faberge Palmolive Products Company J.C. Simko Jr. Harold Stanley Ian Stewart Walter Robert Suffis The S. Thompson R.T. John J. Travers Vanderbire Company a William Waggoner Johnson & Johnson Baby Froducts Company ~ e Norman F. Estrin CTFA eee Mr. Sandland opened the meeting and proceeded with the agenda Re RN 1 Status Review Ain Talc Standards and Methods Re Copies of the proposed specification and methods plus OER copies of letter to Dr. Schaffner were distributed ed to task force members od e status report dated March 8th 1976 prepared by Nn Dr. Petterson on cosmetic talc status was distributed te to those present A copy of an articlbey Re my CONTINUED ON NEXT PAGE nie senirpa CP2-036 Dr. Rohl and Dr. Arthur M. Langer on Identification and Quantitation of Asbestos in Talc was distributed as it appears in Environmental Health Perspectives Volume 9 1974 pp 95-109 Also a copy of the correction the March 1976 Washington Post article on talc of the and the summar dray ft Talk Paper anticipated from the FDA was distributed to those present C. Lewin Samples 8 este ue A DAbisen TR. Ald Mr. Sandland summarized contentosf the November 1975 letter from Henry Davis FDA requesting CTFA apply its methodology to severaolf Dr. Lewin samples provided on a coded basis The results of the analys~ s were described by Dr. Rolle oe Solder Mt. Sinai Analyses old Production Samples bit Dr. Petterson gave detailed background on Dr. Langer's work thie Hestated the objective of the task force should be to de- WE alta velop and collate data that would lead to a presentacion + yale the Miscell Mia scn elelaoneuouss External Panel to attempt to have tale placed in Category I. The results of Dr. Pooley's wezate analyses sponsored by Johnson & Johnson were summarized in mtinaheiatn reported Langer his anaylses on sam- meee tian Torte and stated the sample Dr. Langer Recent Production Data it It was agreed by the task force woul woud ld be extremely beneficial if induvidual companies could provide data to the FDA on recent production Most companies present indicated that they possess such data and would be willing to provide the data Mr. Messinger Chesebrough stated hu would have to confirm this willingness with his management It was suggested each company prepare a letter addressed to Dr. Estrin with a summary of the data on recent production for their products and a commitment to set a subsequent meeting with FDA to discuss this data in detail if FDA so desires This letter should be delivered to Dr. Estrin by Monday March 15th Subsequently a meeting was set for that Monday March 15th at the CTFA offices witha meeting meting at FDA to be held in the afternoon CTFA Study on Current Production Advantages and disadvantageosf having CTFA contract an in- dependent laboratory to do tests on current productioi sam- ples was discussed It was noted that such data would no doubt be useful not only in discussions with FDA but also as part of a presentation to the Miscellaneous External Panel and perhaps to other panels as well it was suggested the CTFA methodology be utilfi orzse ucd h task but thatflTEM thatflTEM CP2-037 be used on those samples that have been shown to be positive CONTINUED ON NEXT PAGE BCST # LEWIN # PRODUCT 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 72 77 96 9.7 101 102A 143 144B 151 154 157A 160 163 75 T73A Lady Ester Face Powder Rachel Touch and Glow Face Powder Blanchard's Dusting Powder Born Wild Dusting Powder Del Labs Tai Winds Spray Talc Avon Tosca Dusting Powder Zow Talque Perf Beauty Prod Overton's High Brown Face Powder Early Ameri Olc d Sa pin ce Talcum Powder Bismoline Medicated Powder Mavis Imported Talcum Avon Beauty Dust Refill - Charisma Pinaud Clubman Talc OH London Talc Yardley Corsage Dusting Powder TREMOLITE LEWI DCST CHRYSOTILE DCST LEWTN NO 2,800 mg ND ND 3 5,600 ND 7 a 13,000 10 - ; 12 60,000 15 ND 15 8,900 ND ND 10 1,800 7 ND 5 400 10 - 5 ND the ND 2,000 22 > ~ 9.000 ND - ub ND 8 22 ND 9,000 trace NO 10 ? 10 - ND I ND 7 NO ND 7 ? CP2-038 by CTFA methodology and also be performed on a random basis on other samples Company representatives were polled at this meeting and previously by Mr. George Lee to determine whether they would be willing to participate in such a study by assur- ing that current production samples would be provided and that financial support be given The results would be made known to the FDA and probably published in some form The _ following cipate companies indicated they would be willing to parti- Avon Products Inc. Palmolive CoBlgarte istol Company Palmolive CoCommppanayny Faberge Inc. . Johnson & Johnson Mennen Sterling Chesebrough In addition be interested Memand Yardley would probably The task force agreed to await the results of the . meetings with CTFA before deciding on whether a study on current produc- tion should be initiated The meeting adjourned in order for a small group to meet with FDA at 2:00 p.m. to discuss the results of CTFA analyses of Dr. Lewin's samples Norman Extrin lase Norman Norman 7 NormaFn. Estrin Ph.D. Vice President -O Science NFE March 12th 1976 CP2-039 _ ia_ in rene . ee ry